Invasive pneumococcal disease in England and Wales: vaccination implications.

Knowledge of the epidemiology of invasive pneumococcal disease (IPD) will aid in planning the use of pneumococcal vaccines. A United Kingdom (UK)-based surveillance in England and Wales (1995-1997) of 11,528 individuals with IPD and a local enhanced surveillance in the Oxford (UK) area (1995-1999) have been analyzed. IPD has a high attack rate in children, with 37.1-48.1 cases per 100,000 infants <1 year old per year, and in older persons, with 21.2-36.2 cases per 100,000 persons >65 years old per year, for England, Wales, and Oxford. The 7-valent conjugate vaccine includes serotypes causing < or =79% of IPD in children <5 years old, but only 66% in adults >65 years old. The data also indicate that IPD varies by serotype, age, and country, emphasizing that the epidemiology of IPD is heterogeneous and requires continued surveillance.

[1]  M. Kolczak,et al.  Cigarette smoking and invasive pneumococcal disease , 2000 .

[2]  E. Lewis,et al.  Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children , 2000, The Pediatric infectious disease journal.

[3]  M. Jones,et al.  Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. , 1999, The Journal of antimicrobial chemotherapy.

[4]  J. Carlin,et al.  Bacterial etiology of serious infections in young infants in developing countries: results of a multicenter study. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.

[5]  R. Huebner,et al.  Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. , 1999, The Journal of infectious diseases.

[6]  J. Scott,et al.  The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. , 1999, Vaccine.

[7]  C. Feldman,et al.  Bacteremic pneumococcal pneumonia in HIV-seropositive and HIV-seronegative adults. , 1999, Chest.

[8]  T. Riordan,et al.  Epidemiology of Streptococcus pneumoniae infections at the Edinburgh City Hospital: 1980–95 , 1999, Epidemiology and Infection.

[9]  M. Rohani,et al.  Epidemiology of Streptococcus pneumoniae infection in Malaysia , 1999, Epidemiology and Infection.

[10]  J. Hanna,et al.  Seroepidemiology of invasive pneumococcal disease in Queensland, 1990 to 1997. , 1998, Communicable diseases intelligence.

[11]  G. Kanra,et al.  Serotypes and antibacterial susceptibility of pneumococci isolated from children with infections in Ankara in relation to proposed pneumococcal vaccine coverage , 1998, Acta paediatrica Japonica : Overseas edition.

[12]  D. Goldblatt,et al.  Hospital admissions in children due to pneumococcal pneumonia in England. , 1998, The Journal of infection.

[13]  E. Hak,et al.  Effectiveness of pneumococcal vaccine , 1998, The Lancet.

[14]  J. Eskola,et al.  Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. , 1998, The Pediatric infectious disease journal.

[15]  N. Andrews,et al.  Invasive pneumococcal infection in South and West England , 1998, Epidemiology and Infection.

[16]  B. Spratt,et al.  Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae , 1998, Molecular microbiology.

[17]  R. Dagan,et al.  Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. , 1997, The Pediatric infectious disease journal.

[18]  M. Nahm,et al.  Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. , 1997, The Journal of infectious diseases.

[19]  M. Leinonen,et al.  Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland , 1997, Epidemiology and Infection.

[20]  J. Henrichsen,et al.  Incidence of invasive pneumococcal disease and distribution of capsular types of pneumococci in Denmark, 1989–94 , 1996, Epidemiology and Infection.

[21]  D. Greenberg,et al.  Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. , 1996, The Journal of infectious diseases.

[22]  D. Greenberg,et al.  Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. , 1996, The Journal of infectious diseases.

[23]  B. Greenwood,et al.  A study of risk factors for pneumococcal disease among children in a rural area of west Africa. , 1996, International journal of epidemiology.

[24]  K. Brown,et al.  Pneumococcal meningitis in the North East Thames Region UK: epidemiology and molecular analysis of isolates , 1996, Epidemiology and Infection.

[25]  K. O'Brien,et al.  Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. , 1996, The Pediatric infectious disease journal.

[26]  J. Hedlund,et al.  Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  S. Gove,et al.  Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies. , 1995, The Pediatric infectious disease journal.

[28]  J. Eskola,et al.  Risk factors for primary invasive pneumococcal disease among children in Finland. , 1995, JAMA.

[29]  B. Gessner,et al.  Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age. , 1995, The Pediatric infectious disease journal.

[30]  D. Musher,et al.  Pneumococcal vaccine after 15 years of use. Another view. , 1994, Archives of internal medicine.

[31]  S. Ameratunga,et al.  Invasive pneumococcal disease in a pediatric population, Auckland, New Zealand , 1994, The Pediatric infectious disease journal.

[32]  D. Parks,et al.  The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990--ethnic differences and opportunities for prevention. , 1994, The Journal of infectious diseases.

[33]  M. Alpers,et al.  Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children , 1993, Epidemiology and Infection.

[34]  J. Hanna,et al.  An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia , 1993, The Medical journal of Australia.

[35]  M. Leinonen,et al.  Epidemiology of invasive pneumococcal infections in children in Finland. , 1992, JAMA.

[36]  R. Dagan,et al.  Epidemiology of invasive childhood pneumococcal infections in Israel. The Israeli Pediatric Bacteremia and Meningitis Group. , 1992, JAMA.

[37]  M. Santosham,et al.  High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. , 1992, Archives of internal medicine.

[38]  P. Baker,et al.  T cell regulation of the antibody response to bacterial polysaccharide antigens: an examination of some general characteristics and their implications. , 1992, The Journal of infectious diseases.

[39]  R. Hurley,et al.  Infantile meningitis in England and Wales: a two year study. , 1991, Archives of disease in childhood.

[40]  R. Norrby,et al.  Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. , 1985, Reviews of infectious diseases.

[41]  W. R. Mccabe,et al.  An outbreak of type 1 pneumococcal pneumonia in a men's shelter. , 1980, JAMA.

[42]  H. Pearson,et al.  Sickle cell anemia and severe infections due to encapsulated bacteria. , 1977, The Journal of infectious diseases.

[43]  D. Musher,et al.  Association Between FcγRIIa-R131 Allotype and Bacteremic Pneumococcal Pneumonia , 2000 .

[44]  J. Carlin,et al.  Conclusions from the WHO multicenter study of serious infections in young infants. The WHO Young Infants Study Group. , 1999, The Pediatric infectious disease journal.

[45]  K. Ekdahl,et al.  Bacteraemic pneumococcal infections in Southern Sweden 1981-96: trends in incidence, mortality, age-distribution, serogroups and penicillin-resistance. , 1998, Scandinavian journal of infectious diseases.

[46]  B. Cookson,et al.  Pneumococci causing invasive disease in Britain 1982-1990. , 1998, Journal of medical microbiology.

[47]  L. Nicolle,et al.  Pneumococcal bacteremia in two tertiary care hospitals in Winnipeg, Canada. Pneumococcal Bacteremia Study Group. , 1996, Chest.

[48]  B. Dautzenberg,et al.  An outbreak of pneumococcal pneumonia in two men's shelters. , 1991, Chest.

[49]  J. Henrichsen,et al.  Chapter XI Laboratory Diagnosis, Serology and Epidemiology of Streptococcus pneumoniae , 1978 .